Biocon's Insulin facility in Malaysia receives EU GMP Compliance Certificate

Image
Capital Market
Last Updated : Sep 08 2017 | 12:10 AM IST

Following inspection by EMA in April 2017

Biocon's subsidiary in Malaysia, Biocon Sdn. Bhd., has been issued a certificate of GMP Compliance for its Insulin manufacturing facility by the HPRA (Ireland) as the representative European inspection authority. Biocon's Malaysia facility was inspected by the EMA in April 2017.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Sep 07 2017 | 5:00 PM IST

Next Story